Locus 60: CYP3A5 (7q22.1)
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs7809615 |
| Chromosomal location | Chr7: 99,022,714 (7q22.1) |
| Gene (distance) | CYP3A5 (-61,034) |
| Predicted causal gene | CYP3A5 |
| Gene/protein classification | metabolic enzyme |
| Metabolite (Pathway) | androsterone sulfate (Sterol, Steroid; Lipid) 4-androsten-3beta,17beta-diol disulfate 2* (Sterol, Steroid; Lipid) |
| Biochemical locus-metabolite relationship | CYP3A5 encodes a P450 with 6beta-hydroxylation activity against multiple steroids, including testosterone and progesterone. [10403825]. Ratio interpretation: androsterone sulfate and 4-androsten-3beta,17beta-diol disulfate 2 conceivably represent a substrate/product pair ('activity'). |
| eQTL associations | CPSF4 (L) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | androsterone sulfate [21886157] (r2=0.145 with rs17277546); Dehydroepiandrosterone sulphate levels [21533175] |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL3019 |
| Drug information |
Substrates: Midazolam, tracolimus, erythromycin, flunitrazepa
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

